At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- Mix of remote tasks and in-person visits
- Drug or intervention
- Exercise (behavioural)
- How long the study runs
- Study runs about 14 months (dates as stated)
- About the drug or intervention
- Exercise — behavioural: 8 week exercise intervention, 3x/wk
- Patient visit burden
- Not specified by the sponsor
In plain English
This study, run by the University of Surrey, is looking at whether online exercise can improve quality of life in men with prostate cancer. The reason for the study is not stated — ask the trial team.
Who can take part
- Men who have had an orchiectomy (surgery to remove the testicles), or are having treatment with a GnRH (gonadotropin-releasing hormone) agonist or antagonist, or are taking Abiraterone, Enzalutamide, Apalutamide or Darolutamide
- Planning to stay on these treatments for at least the next 6 months
Who may not be able to
- Currently having chemotherapy or radiotherapy (men who join the study and later move onto these treatments can still take part)
- High risk of having a heart or circulation event
- A sudden illness, or any bone, joint, muscle, heart or nerve problem that could make exercise unsafe, as decided by checks and their doctor
- Painful or unstable cancer spread to the bone
What taking part involves
- • Not stated — ask the trial team
Time commitment: Not stated — ask the trial team (the study involves online exercise, but how often, for how long, and whether any visits are needed is not stated).
Plain-English summary (AI-generated) from registry data. Not eligibility advice — only the trial team can confirm whether you can take part. Use the eligibility checker to see how your health profile matches this trial.
- Type of study
- Testing a treatment
- Ages
- 18 Years to 99 Years
- Who
- Male
- Number of participants
- 50
- Started
- 2024-04-01
- Last checked
- 2024-12
Plain English Summary
What is this study?
- • Testing a new treatment for prostate cancer
- • NA - 50 participants
- • Currently, there are few opportunities for patients with cancer to have individual exercise guidance, and this has further been impacted by the Covid-19 pandemic
Who can take part?
- • Ages 18 Years to 99 Years
- • Diagnosed with prostate cancer
- • Male only
Where?
- • Guildford - University of Surrey
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
Currently, there are few opportunities for patients with cancer to have individual exercise guidance, and this has further been impacted by the Covid-19 pandemic. However, during the pandemic the use of virtual/remote platforms has been crucial in delivering care to cancer patients. The investigators think that remote exercise training may also offer a solution to support positive change in prostate cancer patients. As a result, the investigators have developed a remote/online exercise programme to explore this further. This study will explore the effectiveness of an 8-week remote exercise and behavioural support intervention, and whether prostate cancer patients feel they benefit from this. The study also aims to see if this sort of exercise programme can be delivered to more prostate cancer patients in the future. This project is open to men with prostate cancer on long term hormone therapy. The intervention will be comprised of one remote supervised session per week, completed 1-1 using an online platform and up to two additional sessions, depending on its suitability for the patient, will be prescribed as unsupervised home-based exercise.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years - 99 Years
- Who can join: Male only
What the study is looking for
- ✓Have had an orchiectomy OR;
- ✓Are receiving a GnRH agonist/antagonist OR;
- ✓Are currently receiving Abiraterone, Enzalutamide, Apalutamide or Darolutamide
- ✓Long-term retention is planned (intending to remain on the above stated treatments for at least the next 6 months).
Who cannot take part
- ✗Patients who are stratified as high risk for having a cardiovascular event.
- ✗Acute illness; or any musculoskeletal, cardiovascular or neurological disorder that could inhibit or put them at...
- ✗Men with painful or unstable bony metastases.
See the full criteria
Where Is This Study? (1 UK site)
University of Surrey
Guildford GU2 7XH, United Kingdom
How to Get in Touch
Ralph Manders, PhD
Sponsor contactCONTACT